# A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye Disease

> **NCT06389214** · PHASE3 · COMPLETED · sponsor: **Aldeyra Therapeutics, Inc.** · enrollment: 132 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** Reproxalap Ophthalmic Solution (0.25%)
- **DRUG:** Vehicle Ophthalmic Solution

## Key facts

- **NCT ID:** NCT06389214
- **Lead sponsor:** Aldeyra Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-09
- **Primary completion:** 2024-06-11
- **Final completion:** 2024-06-11
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06389214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06389214, "A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06389214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*